These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 20417195

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
    Matthias C, Branigan K, Jahnke V, Leder K, Haas J, Heighway J, Jones PW, Strange RC, Fryer AA, Hoban PR.
    Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
    [Abstract] [Full Text] [Related]

  • 23. Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.
    Namazie A, Alavi S, Olopade OI, Pauletti G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES.
    Laryngoscope; 2002 Mar; 112(3):472-81. PubMed ID: 12148857
    [Abstract] [Full Text] [Related]

  • 24. Loss of Fhit expression in head and neck squamous cell carcinoma and its potential clinical implication.
    Tai SK, Lee JI, Ang KK, El-Naggar AK, Hassan KA, Liu D, Lee JJ, Ren H, Hong WK, Mao L.
    Clin Cancer Res; 2004 Aug 15; 10(16):5554-7. PubMed ID: 15328196
    [Abstract] [Full Text] [Related]

  • 25. Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival.
    Pitkin L, Luangdilok S, Corbishley C, Wilson PO, Dalton P, Bray D, Mady S, Williamson P, Odutoye T, Rhys Evans P, Syrigos KN, Nutting CM, Barbachano Y, Eccles S, Harrington KJ.
    Br J Cancer; 2007 Sep 03; 97(5):670-7. PubMed ID: 17687340
    [Abstract] [Full Text] [Related]

  • 26. Topoisomerase II alpha expression in squamous cell carcinomas of the head and neck.
    Stathopoulos GP, Kapranos N, Manolopoulos L, Papadimitriou C, Adamopoulos G.
    Anticancer Res; 2000 Sep 03; 20(1A):177-82. PubMed ID: 10769652
    [Abstract] [Full Text] [Related]

  • 27. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ, Lim KY, Kim JW, Nam IW, Lee JH, Myoung H.
    Cancer Lett; 2005 Jun 28; 224(2):253-61. PubMed ID: 15914276
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Survival analysis and risk factors for recurrence in oral squamous cell carcinoma: does surgical salvage affect outcome?
    Sklenicka S, Gardiner S, Dierks EJ, Potter BE, Bell RB.
    J Oral Maxillofac Surg; 2010 Jun 28; 68(6):1270-5. PubMed ID: 20347201
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Strong correlation between c-erbB-2 overexpression and overall survival of patients with oral squamous cell carcinoma.
    Xia W, Lau YK, Zhang HZ, Liu AR, Li L, Kiyokawa N, Clayman GL, Katz RL, Hung MC.
    Clin Cancer Res; 1997 Jan 28; 3(1):3-9. PubMed ID: 9815530
    [Abstract] [Full Text] [Related]

  • 32. Prognostic value of S-phase fraction in head and neck squamous cell carcinomas and nodal negative breast carcinomas.
    Fietkau R, Iro H, Tulusan AH, Dressel V, Altendorf-Hofmann A, Sauer R.
    Strahlenther Onkol; 1994 Jan 28; 170(1):13-24. PubMed ID: 8303573
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.
    Wang L, Rodriguez M, Kim ES, Xu Y, Bekele N, El-Naggar AK, Hong WK, Mao L, Oh YW.
    Int J Oncol; 2004 Oct 28; 25(4):993-9. PubMed ID: 15375549
    [Abstract] [Full Text] [Related]

  • 36. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA, Nguyen TV, Bova RJ, Kench JG, Cole IE, Musgrove EA, Henshall SM, Sutherland RL.
    Clin Cancer Res; 2003 Sep 01; 9(10 Pt 1):3705-11. PubMed ID: 14506162
    [Abstract] [Full Text] [Related]

  • 37. Prognostic value of plasminogen activator inhibitor-1 in head and neck squamous cell carcinoma.
    Speleman L, Kerrebijn JD, Look MP, Meeuwis CA, Foekens JA, Berns EM.
    Head Neck; 2007 Apr 01; 29(4):341-50. PubMed ID: 17163465
    [Abstract] [Full Text] [Related]

  • 38. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
    Rodriguez-Pinilla M, Rodriguez-Peralto JL, Hitt R, Sanchez JJ, Ballestin C, Diez A, Sanchez-Verde L, Alameda F, Sanchez-Cespedes M.
    Clin Cancer Res; 2004 Dec 15; 10(24):8486-92. PubMed ID: 15623629
    [Abstract] [Full Text] [Related]

  • 39. Role of nitric oxide in the development of distant metastasis from squamous cell carcinoma.
    Scher RL.
    Laryngoscope; 2007 Feb 15; 117(2):199-209. PubMed ID: 17277613
    [Abstract] [Full Text] [Related]

  • 40. Association of acute phase protein-haptoglobin, and epithelial-mesenchymal transition in buccal cancer: a preliminary report.
    Lee CC, Ho HC, Chien SH, Hsiao SH, Hung SK, Huang TT, Yu CC, Chang SM, Huang HH, Su YC.
    Clin Chem Lab Med; 2013 Feb 15; 51(2):429-37. PubMed ID: 23093274
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.